Calcium D-glucarate (CDG)
Calcium D-Glucarate (CDG) · also known as CDG, Calcium D-glucarate, Glucaric acid
Calcium D-glucarate forms a lactone in the gut, which can inhibit some bacterial β-glucuronidase. Evidence for this effect comes mainly from rat studies. There is currently no reliable evidence that it reduces estrogen reabsorption in humans.
Mechanisms of action
Estrogen metabolism shunting and detoxification pathway tuning
CDG is converted into a lactone in the gut, which can inhibit some bacterial β-glucuronidase. This effect has been seen in rat experiments. There is no reliable evidence that it changes estrogen excretion in humans, and the CYP1A1 shunt described on product labels has not been confirmed.
References (3)
- Dwivedi et al. 1990 · Rat study: in groups given a high dose of the calcium salt or a diet containing 4%, β-glucuronidase activity fell in tissues and gut bacteria
- Walaszek et al. 1986 · Rat study: serum β-glucuronidase and endogenous estradiol may have fallen
- Australian TGA 2001 · Regulatory assessment: the TGA reviewed unpublished preliminary human data, but the evidence was not sufficient to establish an effect at usual doses
Safety and drug interactions
With Levothyroxine Needs attention
Calcium supplements taken with levothyroxine reduce its absorption. Calcium D-glucarate has not been specifically studied and contains less calcium, but it is still advisable to take it 4 hours apart from levothyroxine.